We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$111M
2
MO icon
Altria Group
MO
+$83.8M
3
SWK icon
Stanley Black & Decker
SWK
+$60.3M
4
FTI icon
TechnipFMC
FTI
+$55.6M
5
AIG icon
American International
AIG
+$47.7M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
526
DELISTED
Express Scripts Holding Company
ESRX
$7.68M 0.03%
102,883
-41,445
-29% -$2.65M
FIVN icon
527
FIVE9
FIVN
$2.47B
$7.63M 0.03%
306,793
+29,000
+10% +$715K
LVS icon
528
Las Vegas Sands
LVS
$26.7B
$7.62M 0.03%
109,586
+1,617
+1% +$108K
XHR
529
Xenia Hotels & Resorts
XHR
$1.61B
$7.59M 0.03%
351,597
+80,635
+30% +$1.76M
MTOR
530
DELISTED
MERITOR, Inc.
MTOR
$7.59M 0.03%
323,500
+40,900
+14% +$1.03M
SUPN icon
531
Supernus Pharmaceuticals
SUPN
$2.4B
$7.53M 0.03%
189,048
– –
DGL
532
DELISTED
Invesco DB Gold Fund
DGL
$7.5M 0.03%
181,450
+26,845
+17% +$1.09M
FOLD
533
DELISTED
Amicus Therapeutics
FOLD
$7.45M 0.03%
517,990
-182
-0% -$2.5K
SAGE
534
DELISTED
Sage Therapeutics
SAGE
$7.43M 0.03%
45,120
-1,344
-3% -$130K
ENB icon
535
Enbridge
ENB
$106B
$7.34M 0.03%
187,575
+73,773
+65% +$2.84M
CCI icon
536
Crown Castle
CCI
$31.2B
$7.33M 0.03%
66,037
+601
+0.9% +$64.8K
LGIH icon
537
LGI Homes
LGIH
$1.18B
$7.32M 0.03%
+97,600
New +$6.2M
HPQ icon
538
HP
HPQ
$30.5B
$7.32M 0.03%
348,404
+175,600
+102% +$3.73M
TTMI icon
539
TTM Technologies
TTMI
$11.8B
$7.32M 0.03%
466,800
+68,400
+17% +$1.1M
ISCA
540
DELISTED
International Speedway Corp
ISCA
$7.31M 0.03%
183,354
+37,554
+26% +$1.49M
WDR
541
DELISTED
Waddell & Reed Financial, Inc.
WDR
$7.26M 0.03%
324,800
+55,400
+21% +$1.13M
WNC icon
542
Wabash National
WNC
$509M
$7.22M 0.03%
332,800
+92,600
+39% +$1.93M
AA icon
543
Alcoa
AA
$12.3B
$7.2M 0.03%
133,699
+127,200
+1,957% +$5.82M
SCZ icon
544
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
$7.15M 0.03%
110,900
+200
+0.2% +$12.6K
OHI icon
545
Omega Healthcare
OHI
$14.3B
$7.12M 0.03%
258,578
+191,800
+287% +$5.54M
MET icon
546
MetLife
MET
$62.4B
$7.06M 0.03%
139,731
-19
-0% -$1K
ITOT icon
547
iShares Core S&P Total US Stock Market ETF
ITOT
$95.1B
$7.06M 0.03%
115,460
-3,540
-3% -$211K
OEF icon
548
iShares S&P 100 ETF
OEF
$20.1B
$7.05M 0.03%
59,402
– –
CHSP
549
DELISTED
Chesapeake Lodging Trust
CHSP
$7.03M 0.03%
259,300
+71,400
+38% +$2M
ITGR icon
550
Integer Holdings
ITGR
$4.29B
$6.94M 0.03%
153,200
+40,800
+36% +$1.99M
20 21
22
23 24

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.